FDX1 Antibody - #DF7950

>>买2送1 进行中>>
>>赠JD卡 预热中>>
(4)   (2)  
产品: FDX1 抗体
货号: DF7950
描述: Rabbit polyclonal antibody to FDX1
应用: WB IF/ICC
文献验证: WB
反应: Human
预测: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
蛋白号: P10109
RRID: AB_2841351

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售
相关下载
MS Report
HPLC Report
MSDS
说明书
COA
实验方案
WB Handbook
IHC Protocol
IF/ICC Protocol

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000, IF/ICC 1:200-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human
克隆:
Polyclonal
特异性:
FDX1 Antibody detects endogenous levels of total FDX1.
RRID:
AB_2841351
引用格式: Affinity Biosciences Cat# DF7950, RRID:AB_2841351.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

Adrenal ferredoxin; Adrenodoxin; Adrenodoxin, mitochondrial; ADX; ADX_HUMAN; FDX; fdx1; Ferredoxin 1; Ferredoxin-1; Hepatoredoxin; LOH11CR1D; Mitochondrial adrenodoxin; mitochondrial;

抗原和靶标

免疫原:

A synthesized peptide derived from human FDX1, corresponding to a region within the internal amino acids.

基因/基因ID:
FDX1(2230)

文献引用

1). Photodynamic-Photothermal Switching in Osmium-Ferritin Nanoplatform Activates Near Infrared-Driven Tumor Immunity Reprogramming. ACS Nano, 2025 [IF=16.0]
2). Multifunctional drug delivery nanoparticles for combined chemotherapy/chemodynamic/photothermal therapy against colorectal cancer through synergistic cuproptosis/ferroptosis/apoptosis. Materials today. Bio, 2024 (PubMed: 39850244) [IF=8.7]
3). The signature genes of cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma. Frontiers in oncology, 2024 (PubMed: 39206152) [IF=3.5]

Application: WB    Species: human    Sample: Caki-1 cells

Figure 5. Effect of Elesclomol on proliferation and migration of KIRC cells and regulation of FDX1. (A). Caki-1 cells viability was measured using the CCK-8 kit after treating with Elesclomol for 24, 48,72h. (B). EdU staining of Caki-1 cells. Scale bar, 200 μm; n=3; (C). Caki-1 cell EdU flourescence intensity analysis by flow cytometry. (D). The healing/closing state of Caki-1cells by the scratch assay (representative pictures from 3 repeated experiments). (E, F). FDX1 mRNA (E) and protein (F) expression level of Caki-1 cells treated with Elesclomol (500nM) for 48h. (G). The content of Fe-S cluster was tested of Caki-1 cells c treated with Elesclomol (500nM) for 48h. Experiments were repeated three times and the data are expressed as the mean ± SEM. *P < 0.05, ** P
4). Taxifolin regulates SLC31A1-mediated cuproptosis and tumor progression in hepatocellular carcinoma. Human cell, 2025 (PubMed: 39752031) [IF=3.4]

限制条款

产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）

产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.